Key facts
- Cooler Heads’s last known valuation is $27.0M (Jul 2025).
- It has raised $45.7M; the latest was Later Stage VC ($11.0M) in Jul 2025.
- Notable investors include Impact Assets, MedTech Innovator, Gaingels, StartX (US), Endless Frontier Labs — 29 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 29 names
- ·Watchlist + deal alerts for Cooler Heads
- ·The full record, as it builds
Funding rounds
No funding rounds for Cooler Heads are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cooler Heads
Developer of the cold caps system and portable technology designed to help cancer patients maintain their identity. The company's product cools the scalp of patients to prevent hair loss during chemotherapy and gives control over the experience of the side effects of treatment to improve impacts on their entire sense of self, mental health, and recovery, enabling cancer patients to address their needs incurred due to treatment and prevent hair loss.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2018
- Employees
- 29
- Website
- coolerheads.com/
- Ownership
- Privately Held (backing)
Cooler Heads doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cooler Heads shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cooler Heads in its N-PORT filings yet. We sweep new filings monthly.